Prioritizing new malaria vaccine candidates for further development
Prioritizing new malaria vaccine candidates for further development Prioritizing new malaria vaccine candidates for further development
Strategic goals, outcomes, and vaccine targets Goal/impact Control & elimination Saving lives & preventing disease Outcome Transmission interrupted Infections prevented Cases averted* *Impact on asymptomatic reservoir 16
Strategic goals, outcomes, and vaccine targets Goal/impact Control & elimination Saving lives & preventing disease Outcome Transmission interrupted Infections prevented Cases averted* Vaccine target Sexual/ sporogonic/ mosquito (SSM) Preerythrocytic (PE) Blood-stage (BS) 17
- Page 1 and 2: Prioritizing New Malaria Vaccine Ca
- Page 3 and 4: Why prioritize • No need to prior
- Page 5 and 6: Global malaria vaccine pipeline Pha
- Page 7 and 8: What to prioritize • Strategic go
- Page 9 and 10: The Malaria Vaccine Technology Road
- Page 11 and 12: 1 2 Reasons to update the Roadmap
- Page 13 and 14: Updating the Malaria Vaccine Techno
- Page 15: Strategic goals, outcomes, and vacc
- Page 19 and 20: Thoughts on how vaccine candidates
- Page 21 and 22: Cost Low High A commercial-sector m
- Page 23 and 24: Cost Low High A commercial-sector m
- Page 25 and 26: Sources and management of uncertain
- Page 27 and 28: Prioritizing through defining/manag
- Page 29 and 30: Summary • There is an ongoing nee
Strategic goals, outcomes, and <strong>vaccine</strong> targets<br />
Goal/impact<br />
Control &<br />
elimination<br />
Saving lives<br />
& preventing<br />
disease<br />
Outcome<br />
Transmission<br />
interrupted<br />
Infections<br />
prevented<br />
Cases<br />
averted*<br />
*Impact on asymptomatic reservoir<br />
16
Change language